Back
Invesco S&P MidCap 400® Pure Value ETF Vs. Viking Therapeutics Industry Stock Comparison
Buy
68
RFV
Invesco S&P MidCap 400® Pure Value ETF
Last Price:
117.47
Seasonality Move:
6.19%
Buy
53
VKTX
Viking Therapeutics
Last Price:
64.95
Seasonality Move:
34.33%
Buy
68
Invesco S&P MidCap 400® Pure Value ETF (RFV)
is a Buy
Is Invesco S&P MidCap 400® Pure Value ETF a Buy, Sell or Hold?
- The current Invesco S&P MidCap 400® Pure Value ETF [RFV] share price is $117.46. The Score for RFV is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- RFV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $64.96. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RFV Stock Price Chart
What is Invesco S&P MidCap 400® Pure Value ETF's stock price today?
-
The Invesco S&P MidCap 400® Pure Value ETF share price today is $117.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RFV is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $64.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RFV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.82 | Buy |
| Relative Strength Index (14 RSI): | 55.93 | Buy |
| Chaikin Money Flow: | -566 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (112.6 - 118) | Buy |
| Bollinger Bands (100): | (111.58 - 117) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 54.51 | Buy |
| Chaikin Money Flow: | 1135470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.05 - 66.47) | Buy |
| Bollinger Bands (100): | (52.64 - 64.98) | Buy |
RFV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 117.28 | Buy |
| 20-day SMA: | 115.61 | Buy |
| 50-day SMA: | 114.9 | Buy |
| 200-day SMA: | 113.78 | Buy |
| 8-day EMA: | 117.04 | Buy |
| 20-day EMA: | 116.29 | Buy |
| 50-day EMA: | 115.22 | Buy |
| 200-day EMA: | 112.2 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.29 | Buy |
| 20-day SMA: | 63.32 | Buy |
| 50-day SMA: | 60.76 | Buy |
| 200-day SMA: | 55.03 | Buy |
| 8-day EMA: | 63.88 | Buy |
| 20-day EMA: | 63.16 | Buy |
| 50-day EMA: | 61.34 | Buy |
| 200-day EMA: | 52.6 | Buy |
Invesco S&P MidCap 400® Pure Value ETF Earnings Growth & RFV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Invesco S&P MidCap 400® Pure Value ETF Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||